Molecular medicine in the US: can three paradigms shift simultaneously?

Lancet. 1993 May 29;341(8857):1379-80. doi: 10.1016/0140-6736(93)90948-g.

Author

L S Rothenberg¹

Affiliation

¹ Department of Medicine, UCLA School of Medicine.

PMID: 8098797
DOI: 10.1016/0140-6736(93)90948-g

No abstract available

MeSH terms

Biotechnology / economics
Biotechnology / trends*
Costs and Cost Analysis
Health Policy / trends*
Humans
Molecular Biology / economics
Molecular Biology / methods
Molecular Biology / trends*
Primary Health Care / economics
Primary Health Care / trends*
United States